Neubase Therapeutics (NBSE) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 82 253 sessions, May 24, 2023 to May 24, 2024
- Largest daily move
- +107% close of September 6, 2023
- 1-year change
- -90.5% closing prices, May 24, 2023 to May 24, 2024
- 5-year change
- -99.4% closing prices, May 24, 2019 to May 24, 2024
Company Description
Neubase Therapeutics (NASDAQ: NBSE) is classified in the pharmaceutical preparation manufacturing industry within the Pharmaceutical Preparations sector and carries a market capitalization of $1.4M.
NBSE has declined 90.5% over the past year. The last closing price was $0.3780.
This page collects what Stock Titan holds for NBSE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neubase Therapeutics (NBSE) closed at $0.3780 on May 24, 2024. Over the past 12 months, the price has lost 90.5%.
NBSE Metrics & Rankings
Price returns through May 24, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Neubase Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, private placement, offering, stock split, conferences. View all NBSE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NBSE Company Profile & Sector Positioning
Neubase Therapeutics (NBSE) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.